Immatics Biotechnologies GmbH announced the appointment of Katina Dorton as Chief Financial Officer (CFO), effective immediately. Katina brings more than 20 years of experience in investment banking and has served as a senior strategic
advisor to numerous companies in the life sciences, medical devices and healthcare sectors. She is a former
Managing Director Investment Banking, Morgan Stanley in New York and Frankfurt, Germany, serving 12 years at thefirm. She later was Managing Director, Life Sciences, at Needham & Co.